These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7940814)
1. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function. Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814 [No Abstract] [Full Text] [Related]
2. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results. van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787 [No Abstract] [Full Text] [Related]
3. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation. Vanrenterghem Y; Peeters J Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165 [No Abstract] [Full Text] [Related]
4. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine. Kliem V; Repp H; Frei U Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788 [No Abstract] [Full Text] [Related]
6. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation. Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040 [No Abstract] [Full Text] [Related]
7. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation. Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294 [TBL] [Abstract][Full Text] [Related]
8. Long-term cyclosporine A treatment does not progressively impair renal graft function: a 5-year follow-up study. Linder R; Restifo AC; Lindholm A; Groth CG Transplant Proc; 1991 Aug; 23(4):2210. PubMed ID: 1871848 [No Abstract] [Full Text] [Related]
9. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation. Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104 [No Abstract] [Full Text] [Related]
10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
11. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee. Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424 [No Abstract] [Full Text] [Related]
12. First-line cyclosporin A monotherapy in cadaveric renal transplantation. Sells RA; Chandrasekhar P; Aikawa A; Morris A; Ward RG; Bakran A; Bone JM; Bell GM; Brown MW Transplant Proc; 1994 Oct; 26(5):2499-500. PubMed ID: 7940766 [No Abstract] [Full Text] [Related]
13. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation. Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887 [No Abstract] [Full Text] [Related]
14. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage. Sumethkul V; Jirasiritham S; Chiewsilp P Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741 [No Abstract] [Full Text] [Related]
15. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function. Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050 [No Abstract] [Full Text] [Related]
16. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression. Park K; Kim ST; Lee SR; Koh YB; Kim HC Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642 [No Abstract] [Full Text] [Related]
17. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients. Ebel H; Lange H Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463 [No Abstract] [Full Text] [Related]
18. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival. Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816 [No Abstract] [Full Text] [Related]